Work

A randomized phase II clinical trial of enzalutamide in combination with the therapeutic cancer vaccine, PSA tricom, in metastatic, castration resistant prostate cancer.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps5104

Authors: Nishith K. Singh, Joseph W. Kim, Christopher Ryan Heery, William L. Dahut, Anna Couvillon, Myrna Rauckhorst, Sheri McMahon, Jeffrey Schlom, Tito Fojo, Philip M. Arlen, James L. Gulley, Ravi Amrit Madan

Institutions: National Cancer Institute, National Institutes of Health, Center for Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597055476

Cites:

Cited by: 2

Related to: 10